Awakn Life Sciences (Awakn Life Sciences) Total Liabilities : $1.49 Mil (As of Oct. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Awakn Life Sciences Total Liabilities?

Awakn Life Sciences's Total Liabilities for the quarter that ended in Oct. 2023 was $1.49 Mil.

Awakn Life Sciences's quarterly Total Liabilities declined from Apr. 2023 ($3.85 Mil) to Jul. 2023 ($1.53 Mil) and declined from Jul. 2023 ($1.53 Mil) to Oct. 2023 ($1.49 Mil).

Awakn Life Sciences's annual Total Liabilities increased from Jan. 2021 ($0.28 Mil) to Jan. 2022 ($3.05 Mil) and increased from Jan. 2022 ($3.05 Mil) to Jan. 2023 ($3.31 Mil).

Awakn Life Sciences Total Liabilities Historical Data

The historical data trend for Awakn Life Sciences's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Awakn Life Sciences Total Liabilities Chart

Awakn Life Sciences Annual Data

Trend

Jan21

Jan22

Jan23

Total Liabilities

0.28

3.05

3.31

Awakn Life Sciences Quarterly Data
	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23
Total Liabilities	Get a 7-Day Free Trial							3.41	3.31	3.85	1.53	1.49

Awakn Life Sciences Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Awakn Life Sciences's Total Liabilities for the fiscal year that ended in Jan. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1.835	+	(1.422	+	0.053
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	3.31

Total Liabilities	=	Total Assets (A: Jan. 2023 )	-	Total Equity (A: Jan. 2023 )
	=	3.274	-	-0.037
	=	3.31

Awakn Life Sciences's Total Liabilities for the quarter that ended in Oct. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1.487	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	1.49

Total Liabilities	=	Total Assets (Q: Oct. 2023 )	-	Total Equity (Q: Oct. 2023 )
	=	0.796	-	-0.691
	=	1.49

Awakn Life Sciences Total Liabilities Related Terms

Thank you for viewing the detailed overview of Awakn Life Sciences's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Awakn Life Sciences (Awakn Life Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Awakn Life Sciences Corp (OTCPK:AWKNF) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

954:Germany AWKN:Canada

Address

301?217 Queen Street West, Toronto, ON, CAN, M5V 0R2

Website

https://www.awaknlifesciences.com

Awakn Life Sciences Corp is a clinical-stage biotechnology company intended to develop therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder. The Company focuses on Alcohol Use Disorder (AUD), a condition affecting the people in the US and key international markets and many people globally for which the current standard of care is inadequate, enabling to provide breakthrough therapeutics to addiction sufferers in desperate need.

Awakn Life Sciences (Awakn Life Sciences) Headlines

From GuruFocus

CEO Presenting on the Emerging Growth Conference on June 22 Register Now

By PurpleRose PurpleRose • 07-11-2022

KCSA Psychedelics Virtual Investor Conference Agenda Announced for October 13th & 14th

By PRNewswire PRNewswire • 10-11-2021

CEO Presenting on the Emerging Growth Conference on June 22 Register Now

By GuruFocusNews GuruFocusNews • 06-21-2022

CEO Presenting on the Emerging Growth Conference on June 22 Register Now

By GuruFocusNews GuruFocusNews • 07-01-2022